Open-Label Phase 2 Study of Dexamethasone Intravitreal Implant for Treatment of Diabetic Macular Edema (DME) in Vitrectomized Patients: Interim Results

被引:0
|
作者
Gupta, S. [1 ]
Boyer, D. S. [2 ]
Faber, D. [3 ]
Patel, S. S. [4 ]
Liu, C. -C. [5 ]
Li, X. -Y. [6 ]
Whitcup, S. M. [7 ]
机构
[1] Retina Specialists Pensacola, Pensacola, FL USA
[2] Retina Vitreous Assoc Med Grp, Ophthalmol, Los Angeles, CA USA
[3] Rocky Mt Retina Consultants, Salt Lake City, UT USA
[4] Inst Texas, Retina Res, Abilene, TX USA
[5] Allergan Pharmaceut Inc, Irvine, CA USA
[6] Allergan Pharmaceut Inc, Clin Ophthalmol, Irvine, CA USA
[7] Allergan Pharmaceut Inc, R&D, Irvine, CA USA
关键词
corticosteroids; macula/fovea; retina;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
4261
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant
    Cebeci, Zafer
    Kir, Nur
    DIABETES METABOLIC SYNDROME AND OBESITY, 2015, 8 : 555 - 566
  • [32] Twelve-month treatment with intravitreal dexamethasone implant for diabetic macular edema
    Sarao, Valentina
    Veritti, Daniele
    Lanzetta, Paolo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [33] Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema
    Ebru Esen
    Selcuk Sizmaz
    Nihal Demircan
    International Ophthalmology, 2017, 37 : 1 - 6
  • [34] Sustained-release dexamethasone intravitreal implant for treatment of diabetic macular edema
    Kuppermann, Baruch D.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2011, 6 (01) : 11 - 20
  • [35] Letter to the editor: dexamethasone intravitreal implant in the treatment of diabetic macular edema Reply
    Dugel, Pravin U.
    Bandello, Francesco
    Loewenstein, Anat
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 2121 - 2121
  • [36] Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema
    Esen, Ebru
    Sizmaz, Selcuk
    Demircan, Nihal
    INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (01) : 1 - 6
  • [37] PHARMACOECONOMIC ANALYSIS OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF DIABETIC MACULAR EDEMA IN RUSSIA
    Kolbin, A.
    Galankin, T.
    Kaleev, A., I
    VALUE IN HEALTH, 2017, 20 (05) : A158 - A158
  • [38] Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients
    Dang, Yalong
    Mu, Yalin
    Li, Lin
    Mu, Yahui
    Liu, Shujing
    Zhang, Chun
    Zhu, Yu
    Xu, Yimin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 1441 - 1449
  • [39] Dexamethasone Intravitreal Implant at the Time of Cataract Surgery in Patients with Diabetic Macular Edema
    Gusson, Elena
    Panozzo, Giacomo
    Casati, Stefano
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [40] Intraoperative dexamethasone intravitreal implant in diabetic macular edema patients undergoing phacoemulsification: The CataDex study
    Vadala, Maria
    Trapani, Valentina Sunseri
    Amato, Mario
    Bongiovanni, Giuseppe
    Alaimo, Francesco
    Cillino, Salvatore
    Bonfiglio, Vincenza Maria Elena
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (05) : 2760 - 2770